Overview

New Russian public health laws due to come into effect on 1 Jan 2012, reflect an unprecedented surge in interest following the first proposals to amend Russia's core legislation on public health protection. This briefing outlines how both industry players and the public will be affected by far-reaching consequences relating to:

• pharmaceutical and medical equipment company visits to medical practitioners and pharmacists;


• payment for scientific and/or educational studies;


• liability for prohibition breaches established by the bill;


• procedures and standards for medical care;


• rare (or 'orphan') diseases; and


• medical products and substitutability.

To read the full details on these issues, click 'View Briefing'.